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Abstract
Background: Malaria transmission may be considered to be homogenous with well-mixed parasite populations (as in the
classic Ross/Macdonald models). Marked fine-scale heterogeneity of transmission has been observed in the field (i.e., over a
few kilometres), but there are relatively few data on the degree of mixing. Since the Plasmodium falciparum Erythrocyte
Membrane Protein 1 (PfEMP1) is highly polymorphic, the host’s serological responses may be used to infer exposure to
parasite sub-populations.
Methods and Findings: We measured the antibody responses to 46 individual PfEMP1 domains at four time points among
450 children in Kenya, and identified distinct spatial clusters of antibody responses to individual domains. 35 domains
showed strongly significant sero-clusters at p = 0.001. Individuals within the high transmission hotspot showed the greatest
diversity of anti-PfEMP1 responses. Individuals outside the hotspot had a less diverse range of responses, even if as
individuals they were at relatively intense exposure.
Conclusions: We infer that antigenically distinct sub-populations of parasites exist on a fine spatial scale in a study area of
rural Kenya. Further studies should examine antigenic variation over longer periods of time and in different study areas.
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Introduction
Immunity to the blood stage parasites of Plasmodium falciparum
malaria is incomplete, and slowly acquired [1]. Exposure to parasites is
associated with seroconversion to parasite derived red cell surface
antigens, most notably the highly polymorphic PfEMP1 antigens [2,3].
PfEMP1 antigens mediate cytoadherence of infected red blood cells to
host endothelial receptors [4], thereby avoiding circulation through the
spleen (where the host may clear parasites), but also causing cerebral
malaria [5]. PfEMP1 antigens are encoded by var genes, which have
been classified into groups, based on their chromosomal location and 5
prime upstream sequence [6,7]. PfEMP1 antigens contain two main
domain types, Cysteine-rich InterDomain Regions (CIDR), and the
Duffy Binding-Like (DBL) domains. Domains have very diverse
sequences, and PfEMP1 antigens comprise different combinations of
between two and nine domains [6,8].
Spatio-temporal hotspots of malaria transmission have been
identified on a fine scale [9,10], and could become targets for
intensified malaria control measures [11,12,13]. However, we do
not know if there are discrete spatially limited sub-populations of
parasites, and so cannot predict the likely outcomes of different
targeted control scenarios.
In field studies one may find very focal fine scale heterogeneity
of transmission [14,15], or evidence of widespread dispersion of
vectors from known breeding sites [16,17]. However, neither of
these situations directly addresses the mixing of parasites: For
instance, it is theoretically possible to have multiple hotspots of
high transmission with similar parasite populations transmitting
between them, or for what appears to be a single hotspot to have
sub-populations of poorly-mixed parasites within it.
Studies have show quite marked variation of parasite genotype
over short distances (i.e. kms) in Papua New Guinea [18,19] and in
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comparing urban and rural West Africa [20]. However, it is
unclear how these findings relate to hotspots of transmission, and
whether sub-populations of parasites can be identified on a fine
scale in rural Africa.
Seroconversion to the merozoite antigens AMA-1 and MSP119
has been used to identify transmission hotspots [10]. However,
antibodies to these antigens do not appear to identify diverse sub-
populations, perhaps because these antibodies are highly cross-
reactive [21]. Compared with AMA-1 and MSP119, antibodies to
PfEMP1 domains are less cross-reactive [22], suggesting that
differences in parasite populations might be detectable in the host’s
variant-specific response. We had access to samples taken from
900 children in Kilifi (Kenya) and Korogwe (Tanzania) who had
been enrolled in a randomized controlled trial of the candidate
malaria vaccine, RTS,S/AS01E[23]. We measured anti-PfEMP1
antibody responses to 46 different recombinant PfEMP1 domains
from 25 different PfEMP1 antigens on multiple plasma samples.
We analyse demographic and temporal trends by linear regression
and fractional polynomials, respectively. The study was originally
designed to examine the impact of vaccination on blood stage
immunity. However, the geo-spatial coordinates of homestead
location was available in Kilifi, allowing us to identify spatial
clusters of serological responses to particular PfEMP1 domains by
calculating the Scan statistic [24]. We took account of the repeated
measures by clustering the analyses by individual [25], and
adjusting by time and age as fixed effects. Details of the domains
examined can be found in Table S1.
Results
Characteristics of the study area
The study was carried out in two sites, recruiting similar
numbers of children. In Kilifi, Kenya, children were recruited in
two administrative locations (Pingilikani and Junju), within the
Chonyi area in the southern part of Kilifi District. In Tanzania,
children were recruited from the catchment areas of three
dispensaries (Ngombezi, Mbagai and Makuyuni) in Korogwe
district, Tanga Region. Both sites are malaria endemic, with all
year round transmission and two high transmission seasons [26].
The transmission intensity has previously been measured as 22–53
infective bites per year in Junju, Kilifi and 90 bites per year in
Korogwe [27,28], although the present transmission intensity is
probably much lower [29,30]. There are successful ITN
distribution programmes in both countries [31,32], and arte-
mether/lumefantrine was the first line anti-malarial treatment.
Both areas are rural, and most of the population are subsistence
farmers.
Antibody levels
The positive control (tetanus toxoid) and negative control (BSA)
antigens gave geometric mean ELISA scores of was 32.4 (95%CI
29.3–35.9) and 0.120 (95%CI 0.115–0.123), respectively. Individ-
ual PfEMP1 domains had a wide range of geometric mean titers
from 0.171 (95%CI 0.163–0.179) for domain 43 (a CIDR domain
from a type C PfEMP1) to 16.3 (95%CI 15.4–17.2) for domain 36
(a DBL domain from a type BA PfEMP1). Details of the domains
examined can be found in Table S1, and mean antibody responses
are shown graphically in figure 1.
Confirmation of expected associations between antibody
responses and age
Age was associated with an average rise in antibody responses of
2.3 fold (95%CI 2.2–2.5 fold) over the interquartile age range of
11 to 22 months. This was strongly significant for 30 domains
(p,1610210) and significant at p,0.001 for a further 44 domains.
Domain 46 shows steeply falling antibody responses with
increasing age. This domain is part of VAR2CSA [33], which is
expressed only during placental infection. Thus, antibodies are
acquired in passively transferred maternal antibody and subse-
quently decay. Tetanus vaccine is given at 1 to 3 months of age,
and we observed a 0.9 fold fall in anti-tetanus toxoid responses
over the age range tested, i.e. 5 to 34 months (p = 1610211). No
significant variation with age was seen for bovine serum albumin
(1.003 fold increase, p= 0.94). The best fit age profiles of
individual antibody responses are shown in Figure S1 (adjusted
for calendar date). Best-fit lines for domains 5, 8, 9 and 10 (and
other domains) in Korogwe show waning antibody in young
children followed by increasing production in older children. In
contrast, best fits for domains 1, 6, 7, 8, 9 and 10 (and others) in
Kilifi indicate rapid acquisition of antibodies in young children
followed by a saturation of response in older children.
Principal component analysis
To reduce the complexity of analysis, we derived three principal
components from the 46 PfEMP1 domains. The 1st principal
component showed strong positive correlations with all domain
antibodies (mean r.0.4) and explained 48% of the variability of
the data set. The 2nd principal component explained a further 6%
of the variability and was most strongly positively correlated with
response to individual CIDR domains (mean correlation 0.12,
95%CI 0.06–0.19) and not strongly negatively or positively
correlated with response to DBL domains (mean correlation
20.03, 95%CI 20.08 to 0.01). The 3rd principal component
explained 4% of the variability with no trend of correlations with
domains of a particular type. Subsequent components explained
,3%, were no more informative than responses to a single
domain, and so were discarded.
We were concerned that the first principal component might
simply reflect exposure to malaria per se. The principal
component analysis was re-run including antibody responses to
four merozoite antigens (AMA1, EBA-175, MSP1-42 and MSP3),
to test whether anti-PfEMP1 domain antibodies and merozoite
antibodies would fall into different principal components. In this
combined analysis, the first principal component correlated highly
with the first principal component of the anti-PfEMP1 only
analysis (r = 0.99), but did not correlate with any of the antibodies
to merozoite antigens (r = 0.01, 0.01, 0.02 and 0.01, respectively).
The 2nd and 3rd principal components from the combined analysis
correlated with the merozoite antigens (range r = 0.3 to 0.35), but
not to anti-PfEMP1 domain responses. Hence, antibodies to
merozoite antigens contributed to different principal components
compared with antibodies to PfEMP1 domains. We took the anti-
PfEMP1 only principal components forward for further analysis.
Principal components and age
The anti-PfEMP1 principal components captured the age-
profile patterns seen with individual anti-domain response.
Increasing age was associated with acquiring anti-PfEMP1 domain
antibodies in both Kilifi and Korogwe, as shown by the 1st
principal component and by the overall means (Figure 1). In
Korogwe the rate of acquisition was constant over the age range
tested (5–34 months), but in Kilifi antibody responses appeared to
‘‘saturate’’ past 10 months, and the curve became less steep. In
contrast, the curve plotted by the 2nd principal component against
age showed an initial steep increase in children below 10 months
in Korogwe, and then became flat. In Kilifi, the 2nd component
formed a shallow biphasic curve. The 3rd principal component was
also biphasic, with a rapid change in children below 10 months of
Anti-PfEMP1 Antibodies Form Spatial Clusters
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21711
age (during the time of decaying maternal antibody), followed by a
more gradual reversal of this change in older children. Date
profiles for individual domains and principal components are
shown in Figures S2 and S3.
The principal components did not vary by insecticide treated
bednet (ITN) use, and RTS,S/AS01E vaccination was associated
with reduction in the first principal component of borderline
significance (Table S2). This corresponded with the analysis of
individual anti-PfEMP1 domains: ITN use was associated with
small, non-significant reductions in antibody responses (p,0.05
for 2 domains) and vaccination with RTS,S/AS01E was
associated with significantly lower responses for 4 individual
domains at p,0.001 and a further 13 domains at p,0.05 (the
effect size ranging from 0.01 fold to 0.5 fold decreases). The mean
antibody levels, principal component analysis, and effects of age,
date, ITN use and vaccination are summarized in the heat map
in figure 2.
Geographical clustering of antibody responses
We found fine scale geographical clustering of the serological
responses in Kilifi, where children’s residences were distributed
evenly over a 22610 km area. In Korogwe, residences were in
close knit groups along two lengths of road, and so were not
examined further for fine scale geographic variation. SaTScan
software was used to identify clusters of high anti-PfEMP1 domain
antibody responses using the normal distribution scan[24]. We
have previously used SaTScan to identify groups of homesteads at
higher transmission intensity, for which we used the term
‘‘hotspot’’[9]. Anti-PfEMP1 antibody responses do not necessarily
indicate transmission intensity. We therefore refer to ‘‘clustering’’
of particular anti-PfEMP1 antibody responses and ‘‘hotspots’’ of
indicators of transmission intensity (i.e. malaria incidence and anti-
AMA1 antibody responses).
When analysed individually, 35 domains showed strongly
significant sero-clusters at p = 0.001 (Figure 3). A further nine
showed significant sero-clusters at p,0.05, and only two domains
(numbers 7 and 46, the pregnancy associated VAR2CSA) did not
cluster significantly. 20 of the 44 significant sero-clusters grouped
in the south-west part of the study area. However, four clusters (i.e.
for domains 16, 18, 20 and 34) were to the south of this focus, and
five domains (i.e. 1, 24, 36, 37 and 44) were to the north of this
focus. Ten domains formed sero-clusters large enough to include
both the south-west and the southern area. Every homestead in
which a child was sampled was included in at least one cluster.
Figure 1. The best fit lines for age vs principal components (panels a–c) and overall mean anti-PfEMP1 antibody responses (panel
d) for Korogwe and Kilifi (adjusted by calendar date). The shaded area indicates 95% confidence intervals, and the dots indicate individual raw
data points.
doi:10.1371/journal.pone.0021711.g001
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Anti-bovine serum albumin (BSA) antibody responses did not
significantly cluster. Tetanus toxoid antibody responses formed a
cluster in the north-east. The largest dispensary is located in the
center of this cluster, and is the chief source of anti-tetanus
vaccination in the study area.
To more readily visualize these patterns, we plotted spatial
clusters based on the three principal components of anti-PfEMP1
responses. The hotspot of transmission indicated by clinical
malaria episodes (p = 0.001) and antibody responses to the
merozoite antigen AMA-1 (p = 0.006) coincided with the 1st
principal component cluster for anti-PfEMP1 domain responses
(p = 0.001) in the south-west of the study area between Feb/March
and August 2008 (figure 4). The 2nd principal component formed a
concurrent cluster of positive values 7 kilometres to the North-east
(p = 0.001), and an earlier cluster of negative values (Jan–June
2007) just to the South (p= 0.002). The 3rd principal component
formed an earlier cluster (July 2007–Mar 2008) four kilometres to
the North-east (p = 0.04).
Heterogeneity of exposure by individual within hotspots
Some children living within the high transmission hotspot did
not experience an episode of malaria and had low AMA-1
antibody responses. Conversely, some children outside the hotspot
had episodes of malaria and high AMA-1 antibody responses.
Hence, although geographically the 1st principal component sero-
cluster overlapped the high transmission hotspot (Figure 4, Table
S3), when analysed by individual the 1st principal component did
not correlate with transmission intensity (Table S4). This can be
seen graphically by comparing the intensity of shading of
homesteads between the panels of figure 4: Despite the 1st
component sero-cluster overlapping the transmission hotspots
(indicated by AMA-1 antibody and malaria episodes), the
individuals at highest exposure intensity (i.e. highest AMA-1
antibody responses or malaria episodes) did not necessarily have
high anti-PfEMP1 1st principal component values.
In order to examine the diversity of anti-PfEMP1 domain
responses, we calculated the variance of anti-PfEMP1 domain
Figure 2. Heatmap of variation in antibody responses to 46 different PfEMP1 domains. The PfEMP1 category and domain category are
shown by a colour code in the first two rows (see key at bottom of figure). The third row shows the intensity of mean antibody responses. The
positive control (tetanus toxoid) and negative control (BSA) antigens gave geometric mean ELISA scores of 32.4 (95%CI 29.3–35.9) and 0.120 (95%CI
0.115–0.123), respectively. Individual PfEMP1 domains had a wide range of geometric mean response from 0.171 (95%CI 0.163–0.179) for domain 43
(a CIDR domain from a type C PfEMP1) to 16.3 (95%CI 15.4–17.2) for domain 36 (a DBL domain from a type BA PfEMP1). The 4th–6th rows show each
domains contribution to a principal component analysis. The effect size and significance of the following independent variables is shown; Age, Date,
Vaccination with control vaccine vs RTS,S/AS01E, ITN use, episodes of malaria and site (Korogwe vs Kilifi). Green shading indicates a positive effect on
antibody responses, red shading indicates a negative effect. The thick black boxing indicates p,0.001, thin black boxing indicated p,0.05. The effect
size for continuous variables (age and date) is scaled so that the inter-quartile range is comparable to a single category.
doi:10.1371/journal.pone.0021711.g002
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responses for each individual (i.e. low variance indicates similar
responses by that individual to a range of domains, high variance
indicates a range of high and low responses). The individual
variances decreased with age, but increased with markers of recent
intensity of exposure such as AMA-1 antibody responses or a
positive malaria slide (Table S5). This implies that over the long
term exposure results in an accumulation of diverse responses to
anti-PfEMP1 domains, but in the short term, intense exposure skews
the response towards a limited number of domains. However, in the
1st principal component hotspot (where transmission was high) the
variance of anti-PfEMP1 responses was reduced (i.e. the high
responses in the hotspot were not skewed to particular domains).
Discussion
We have demonstrated that the host response to polymorphic
parasite antigen (PfEMP1) is spatially clustered at a fine scale. This
was demonstrated using the responses to 46 different individual
PfEMP1 domains, and also using the first three principal
components of these responses.
The hotspot of transmission coincided with the 1st principal
component cluster for anti-PfEMP1 domain responses, but the 2nd
and 3rd principal components clustered outside the transmission
hotspot. Although geographically the 1st principal component
sero-cluster overlapped the high transmission hotspot (Figure 4), at
the level of individual, the 1st principal component did not
correlate with transmission intensity (Table S4).
Taking these findings together with the different associations of
the principal components at the individual and geographical levels
we suggest the following explanation: Hotspots of exposure include
the greatest circulating parasite population, and therefore the
greatest diversity of PfEMP1 expression. Outside the hotspot,
fewer parasites are circulating and therefore diversity is lower.
However, at the individual level, intensity of exposure and
diversity of parasites within that exposure are different things.
For instance, a child living in a low-incidence homestead within
the hotspot may be exposed to few infections containing very
diverse parasites. On the other hand, a child living in a high-
incidence homestead outside the hotspot might be heavily exposed
to a less diverse parasite population.
Figure 3. Scatter plots of anti-PfEMP1 domain specific sero-clusters are shown by homestead residence in Kilifi only (longitude vs
latitude). The mean responses and 95% confidence intervals inside and outside the hotspot are shown on a log scale to the left of each scatter plot.
Red or green shading shows location inside or outside the hotspot, respectively. For example, domain number 1 (top left panel) is from a group A
PfEMP1 (1, orange), is a CIDR domain (2, blue), and shows statistically significant clustering at the p= 0.001 level (3, red), antibody responses within
the cluster are well above the 95% CI for responses outside (boxed plot of two points with confidence intervals), and on an aerial view the hotspot is
in the North-east of the study area (indicated by the red spots).
doi:10.1371/journal.pone.0021711.g003
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As expected, there were also variations in antibody responses by
age. Best-fit lines for domains 5, 8, 9 and 10 (and other domains) in
Korogwe are taken to indicate waning maternal antibody in young
children followed by increasing endogenous production in older
children. This is consistent with the historically very high
transmission intensity in Korogwe resulting in higher maternal
antibody levels [34]. In contrast, best fits for domains 1, 6, 7, 8, 9
and 10 (and others) in Kilifi indicate rapid acquisition of antibodies
in young children followed by a saturation of response in older
children, consistent with the higher transmission intensity in Kilifi
compared with Korogwe during the period of study [23]. Domain
46 shows steeply falling antibody responses with increasing age.
This domain is part of VAR2CSA[33], which is expressed only
during placental infection. Thus, antibodies are acquired in
passively transferred maternal antibody and subsequently decay.
What are the caveats to these data? Firstly, we tested PfEMP1
domains based on the 3D7 of the FCR3 falciparum isolates, which
may not necessarily reflect those circulating locally in Kenya or
Tanzania. However, antibody acquisition was age dependent and
associated with parasite exposure, suggesting that there is
detectable cross-reactivity between the recombinant domains
and those that were actually present in the population. Secondly,
principal components cannot be assumed to have underlying
biological significance and should not be over-interpreted [35].
However, all the inferences we make can be supported by the
results of individual anti-PfEMP1 domain responses, and the
principal components are presented as a more accessible summary
of the individual domain associations. Finally, our original aim was
to examine the effect of vaccination on anti-PfEMP1 recognition
(which turned out to be minor) and the study of spatial clusters was
opportunistic. The risk of a spurious finding rises on secondary
analysis. However, the spatial clustering was strongly significant
(p = 0.001 for 35 of 46 domains and p,0.05 for 9 of the remaining
11 domains), so a type I error is unlikely.
The discrete clusters of serological responses are unlikely to be
explained by the host. The study population comprises a single
ethnic group who depend on subsistence farming throughout.
Furthermore, the sero-clusters were limited in time as well as
space, despite repeated sampling of the same individuals for the
duration of the study.
The discrete sero-clusters more likely indicate diverse sub-
populations of circulating parasites. This could result from
selection pressure as a result of geographic mosaicism, (i.e.
interspersed ecosystems with different selection pressure)[36], or
simply founder effects in poorly mixed sub-populations. We have
previously shown that the environmental factors that determine
transmission hotspots can be detected by the MODIS sensor on
board two NASA satellites [9,37]. We re-confirmed the association
between MODIS data and transmission intensity in our present
study (Table S6), but we did not find that MODIS data predicted
the anti-PfEMP1 domain antibody principal components. Fur-
thermore, var genes interact with host immunity and influence
pathogenicity [38,39,40], and an ecological selection pressure on
var genes seems unlikely. It is possible that very high linkage
Figure 4. Hotspots for clinical malaria episodes, anti-AMA-1 antibodies and for the first 3 principal components of antibody
responses to 46 different PfEMP1 domains are shown in Kilifi. The intensity of the red or green spots indicates the range of the principal
component, but red or green shading depends on being inside or outside the hotspot, respectively. The time period during which each sero-cluster
was present and the statistical significance of the scan statistic is indicated above each panel.
doi:10.1371/journal.pone.0021711.g004
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disequilibrium might cause an apparent ecological selection, but
this could only influence a minority of var genes[41]. Taken
together, we conclude that host responses are spatially heteroge-
neous because of founder effects among different sub- populations
of parasites [42].
The emergence of sub-populations of parasites is likely to
depend on transmission intensity , the distribution of human
populations and vector breeding sites [43], and the dispersion
distance of the vector. We demonstrate evidence for discrete sub-
populations of parasite in the host serological response in an area
of rural Kenya at low to moderate transmission intensity, where
the vector has an average dispersion distance of 0.5 km [44].
Targeting control measures on transmission clusters of infec-
tious disease may be viewed simply as a means of targeting
resources on those who most need it. However, if done on a
sufficiently fine scale, it will benefit the wider community by
reducing overall transmission intensity [43,45]. Our data suggest
that, in addition, such targeted interventions may reduce the
diversity of the circulating parasite population, and thus be of even
greater benefit than first thought.
Methods
Study design
Antibody titers were measured using samples from a random-
ized, controlled trial designed to evaluate the efficacy and safety of
RTS,S/AS01E against clinical malaria episodes by P. falciparum
infection (ClinicalTrials.gov number, NCT00380393). The study
was conducted in Kilifi, Kenya and Korogwe, Tanzania.
Ethics statement
The study and amendments received ethical and scientific
approval from Kenyan Medical Research Institute National Ethics
Committee, the Oxford Tropical Research Ethics Committee, the
London School of Hygiene and Tropical Medicine Ethics
committee and the Western Institutional Review Board in Seattle.
The study was overseen by an Independent data monitoring
committee and local safety monitors, and conducted in accordance
with the Helsinki Declaration of 1964 (revised 1996) and Good
Clinical Practice guidelines. Only children whose parent(s) or
guardian(s) gave written informed consent were enrolled. Ap-
proved Swahili or Giriama consent forms were used. Illiterate
parents thumb printed the consent form, countersigned by an
independent, literate witness. These consenting arrangements
were approved by the IRBs listed above.
Clinical trial
Details have been published previously [23]. Briefly 894, children
5–17 months old were randomized and received either RTS,S/
AS01E or rabies vaccine in a 1:1 ratio according to 0, 1, 2 month
schedule. Both vaccines were given intramuscularly at the left deltoid.
The double blind phase was completed after an average of 8 months
follow up (with the clinic visit in March 2008) [23]. Investigators were
unblinded, but parents of study participants remained blind. The
single blind phase continued on both sites until 12 months post dose
3, and was then further extended in Kilifi, Kenya until October 2008.
Monitoring for episodes of clinical malaria
The primary endpoint was a clinical episode of malaria, defined
as an axillary temperature greater than or equal to 37.5 degrees
Celsius, with a Plasmodium falciparum parasitemia greater than 2,500
parasites per mL. Active surveillance was implemented with weekly
home visits by fieldworkers to identify febrile children. Passive
surveillance was implemented by fieldworkers and in the health
facilities in the study area. Unintentionally, the implementation of
active case detection was delayed by 3 months in Korogwe, but
passive case detection was conducted during this period.
Blood samples
Blood was taken for serological studies before vaccination, one
month post dose 3, then on March 2008 irrespective of the time of
recruitment (i.e. between 4 and 10 months post dose 3, mean 8
months), 12 months post dose 3 and in October 2008 (irrespective
of time of recruitment, i.e. between 12 and 18 months post dose 3,
mean 15 months).
Protein expression
46 recombinant proteins representing domains present in
PfEMP1s encoded by var genes in different parasite genomes
were expressed. The domains were chosen to represent PfEMP1s
belonging to different groupings (groups A, B/A, B, C and
E),domains of different types (a, b, c, d, e or f) or belonging to
various semi-conserved domain cassette structures (Table S1, [6]).
Protein expression was performed essentially as described
previously (1,3). Primer pairs were designed to contain restriction
enzyme sites and used to amplify DBL-encoding fragments from
3D7 genomic DNA. The digested PCR products were cloned into
the Baculovirus vector pAcGP67-A (BD Bioscience), designed to
contain a V5 epitope upstream of a histidine tag in the C-terminal
end of the construct. The identity of the cloned fragments was
verified by sequencing. Linearized Bakpak6 Baculovirus DNA (BD
Biosciences Clontech) was co-transfected with pAcGP67-A into
Sf9 insect cells for generation of recombinant virus particles.
Histidine-tagged proteins secreted into the supernatant of infected
High-Five insect cells were purified on Co2+metal-chelate agarose
columns. Eluted products were dialyzed overnight against PBS,
and verified by SDS-PAGE and western blotting using anti-V5
antibodies. Based on these assays the purity of the recombinant
proteins varied between 79 and 90 percentage.
Covalent coupling of recombinant PfEMP1 proteins to
microspheres
Carboxylated luminex microspheres were covalently coupled
with the different PfEMP1 domains according to the manufacturer’s
protocol. Each protein was coupled to a particular fluorescence-
coded microsphere type. In each case, the microspheres (1.256107/
ml) were washed repeatedly in distilled water, activated in
NaH2PO4 buffer, reacted with 1-ethyl-3-[3dimethylaminopropyl]
carbodiimide hydrochloride and N-hydroxysulfosuccinimide
(Pierce Biotechnology, Rockford, IL), washed twice in 2-[N-
morpholino] ethanesulfonic acid, and covalently linked to the
target protein (100 mg/ml microsphere suspension). Equal volumes
of microspheres coupled with individual domains were pooled,
mixed, split into single-use aliquots, lyophilized in polypropylene
vials, sealed under nitrogen gas and stored at 280uC.
Luminex analysis of plasma samples
The analysis of plasma domain-specific IgG levels was as described
previously (2). In brief, lyophilized microspheres were reconstituted
with distilled water immediately prior to use, and diluted 1:333 in
Assay Buffer E (ABE; 0.1% BSA, 0.05% Tween-20, 0.05% sodium
azide in PBS, pH 7.4). Aliquots (50 ml) were dispensed into the wells
of 1.2 mm filter-bottom 96-well microtiter plates (MSBVS 1210,
Millipore) pre-wetted with ABE buffer, and washed three times with
ABE using a vacuum manifold (Millipore, USA). Frozen plasma
samples were thawed at room temperature, mixed by vortexing, and
spun (16,000 x g; 5 min) to remove particulates. Plasma samples were
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diluted 1:80 in ABE buffer and 50 ml aliquots added to the
microsphere wells. After incubation in the dark on a shaking platform
(30sec at 1,100 rpm followed by 30 min at 300 rpm), the plates were
washed three times in ABE to remove unbound antibody.
Biotinylated anti-human IgG (Sigma) antibody (25 ml/well at 1:500
dilution) was added to the microspheres, which were incubated and
washed as above. This was followed by streptavidin-phycoerythrin
(Sigma) (50 ml/well at 1:500), incubation in the dark with shaking (30
sec at 1,100 rpm followed by 10 min at 300 rpm), and washing as
above. Finally, the microspheres were re-suspended in 125 ml of ABE
and analyzed on a Luminex 100IS instrument set to read a minimum
of 100 microspheres per microsphere region. Antibody levels for each
domain were expressed as median fluorescent intensity (MFI).
Reactivity to beads coated with a recombinant protein consisting of
a stretch of peptides not found in the protein databases and expressing
parts of the Baculo vector including the V5 antibody tag and the
stretch of Histidines used for purification was also measured and
subtracted from theMFI values obtained to the antigen coated beads.
Median fluorescence indexes from the luminex bead studies were
converted to scores by comparison with previously well-characterized
serum samples from endemic and non-endemic area. The final score
was log-transformed to produce a normal distribution.
Regression models
Multivariable linear regression models were constructed of the
antibody levels to each domain, with the explanatory variables age
(in months), calendar date (in days), ITN use, geographical
location (Kilifi vs Korogwe), vaccination status (as an interaction
with time-period, with the fixed effects pre vs post vaccination; and
RTS,S/AS01E vs Rabies vaccination, and the interaction between
the two to represent the examine whether the vaccinated group
differed after vaccination only or throughout monitoring). The
results of regression models were displayed using a heat map
(Figure 2), in which the effect size (i.e. coefficient) was used to
determine the density of shading for each square and a boxed
outline was used to indicate significance (a thick-lined box for
p,0.001 and thin-lined box for p,0.05).
Fractional polynomials
Fractional Polynomials were used to examine for non-linear
effects of age and calendar date, using the ‘‘mfp’’ command in
Stata 10TM, using a significance level of p = 0.05 to retain the
more complex model.
Interactions between age/date and site
Multivariable linear regression models were constructed as
described above with an additional interaction term for age/
date*site. Since transmission intensity was different in both sites,
the data were normalized by multiplying all antibody levels in
Kilifi by a constant such that the overall mean antibody level was
similar to that in Korogwe. The models with interaction terms
were then re-run on this normalized data.
Hotspots
The SaTScan software [46] was used to calculate the spatial scan
statistic for a normally distributed continuous variable [24]. The
spatial scan statistic uses a scanning window that moves across
space. For each location and size of the window, the observed and
expected result is compared, and the window with the greatest ratio
of observed to expected result noted. The statistical significance of
this cluster (or ‘‘hotspot) is then evaluated taking into account the
multiple tests for the many potential cluster locations and sizes
evaluated [47]. P values were calculated after 1000 permutations.
Principal component analysis
Stata 10TM was used to derive the first three orthogonal
components from all the anti-PfEMP1 domain antibody levels (i.e.
excluding BSA and tetanus toxoid). Variables were transformed to
give mean=0, variance=1. Principal components were extracted
and the first three retained. The unrotated components were retained
for further analysis. Repeated measures were used per individual, and
so time was used as a fixed effect in all subsequent analyses.
Supporting Information
Figure S1 The best fits lines for age vs antibody responses for 46
PfEMP1 domains (1–46) and 2 control antigens (tetanus toxoid, TT,
and bovine serum albimun, BSA) are shown for the two sites (Korogwe
and Kilifi) in columns 1 and 2. The log scaled y axes are re-scaled for
each antigen, but consistent between the two sites. The color-coding
system indicates the major group classification of parent PfEMP1
(column 3) and domain type (column 4), the range of the y axis (column
5), the significance of the non-linear fits forKilifi andKorogwe (columns
6 and 7) and the significance of the interaction between age and site
(column 8), and the significance of the interaction after normalizing the
antibody responses for the differentmeans between sites (column 9). For
example, domain number 1 (top left panel) shows steadily increasing
antibody responses with age in Korogwe (column 1), a rapid increase
with age in younger children followed by a plateau inKilifi (column2), is
from a group A PfEMP1 (column 3, orange), is a CIDR domain
(column 4, blue), the range of antibody responses on the y axis cover
nearly a 630% increase (column 5, intense blue), a non-linear fit is non-
significant for Kilifi (column 6, black), but significant in Korogwe
(column7, intense red), there is a strong interaction between age and site
(column 8, intense red), but this interaction is non-significant after
normalizing results for transmission intensity (column 9, black).
(TIF)
Figure S2 The best fits lines for date vs antibody response for 46
PfEMP1 domains and two control antigens (tetanus toxoid and
BSA) are shown for the two sites (Korogwe and Kilifi) in columns 1
and 2. The y axes are re-scaled for each domain, but consistent
between the two sites. The color-coding system indicates the major
classification of parent PfEMP1 (column 3) and domain type
(column 4), the range of the y axis (column 5), the significance of the
non-linear fits for Korogwe and Kilifi (columns 6 and 7) and the
significance of the interaction between age and site (column 8), and
the significance of the interaction after normalizing the antibody
responses for the different means between sites (column 9).
(TIF)
Figure S3 The best fit lines for date vs principal components
(panels a–c) and overall mean anti-PfEMP1 antibody responses
(panel d) for Korogwe and Kilifi (adjusted by calendar date). The
shaded area indicates 95% confidence intervals, and the dots
indicate individual raw data points.
(TIF)
Table S1 Details of antigens tested, numbering system, PfEMP1
group and domain class.
(DOCX)
Table S2 Coefficients for the effect of vaccination with RTS,S/
AS01E and ITN use on principal components and log transformed
mean of anti-PfEMP1 domain antibody responses.
(DOCX)
Table S3 Markers of transmission intensity within clusters
determined by principal components of anti-PfEMP1 domain
antibody responses.
(DOC)
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Table S4 Correlations between anti-PfEMP1 domain antibody
response principal components and markers of transmission
intensity by individual homestead.
(DOC)
Table S5 Multivariate regression for 1st principal component of
anti-PfEMP1 domain antibody response and individual variance
of the 46 anti-PfEMP1 domain responses.
(DOC)
Table S6 Correlations between malaria episode incidence, anti-
PfEMP1 antibody responses and MODIS satellite data.
(DOC)
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